Dose Finding in Late-Phase Drug Development

Therapeutic Innovation & Regulatory Science
Lei NieRajeshwari Sridhara

Abstract

A drug may fail or raise concerns that must be addressed in later-phase trials because of an unacceptable toxicity profile, even if the drug meets expectations for efficacy. The problem could be due to the late onset of unacceptable toxicities that were not observed in early-phase trials. We explore methodologies to find appropriate doses in situations where a drug meets the primary efficacy objective but concerns about toxicity remain. In this manuscript, we propose a general framework to design a good phase IV trial that is designed to optimize the treatment regimen. In the first step, we learn from the existing data about the dose-response and dose-toxicity relationships and further to explore and establish the relationship using a statistical model. Noting the limitations of the exploratory analyses, these analyses are not sufficient to allow us to make definitive conclusions. However, the prediction obtained from the model, either estimated efficacy metrics or safety parameters for some doses, can be incorporated in the design of the phase IV trial. In the second step, we further propose and compare design options, including options that could effectively incorporate information from these exploratory analyses, for clinica...Continue Reading

References

Apr 15, 1997·Statistics in Medicine·L JosephP Bélisle
Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Feb 19, 2004·Biometrics·Anastasia Ivanova
Sep 2, 2004·Biometrics·Peter F Thall, John D Cook
Mar 2, 2005·Biometrics·Kai Wang, Anastasia Ivanova
Dec 18, 2007·Biostatistics·B Nebiyou BekelePeter F Thall
Mar 1, 2012·Journal of the American Statistical Association·Ying Yuan, Guosheng Yin
Nov 30, 2012·The New England Journal of Medicine·Jorge E CortesMoshe Talpaz
Nov 5, 2013·The New England Journal of Medicine·J E CortesUNKNOWN PACE Investigators
Apr 8, 2014·The Annals of Applied Statistics·Suyu LiuYing Yuan
Jun 3, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lei NieDinesh P de Alwis

❮ Previous
Next ❯

Citations

Jun 14, 2019·Pharmacogenomics·Claire-Cécile BarrotNicolas Picard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.